These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 19772941

  • 1. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.
    Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS, Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):243-53. PubMed ID: 19772941
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates and osteonecrosis of the jaw: a retrospective study.
    Murad OM, Arora S, Farag AF, Guber HA.
    Endocr Pract; 2007 Feb; 13(3):232-8. PubMed ID: 17599853
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 6. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R, Need A, Hughes T, Goss A.
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [Abstract] [Full Text] [Related]

  • 7. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry.
    Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shuler CF.
    J Am Dent Assoc; 2009 Jan; 140(1):61-6. PubMed ID: 19119168
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 9. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.
    Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A.
    J Periodontol; 2007 Sep; 78(9):1664-9. PubMed ID: 17760533
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
    Ulmner M, Jarnbring F, Törring O.
    J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN.
    Barasch A, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena D, Voinea-Griffin AE, CONDOR Collaborative Group, Beadnell S, Craig RG, DeRouen T, Desaranayake A, Gilbert A, Gilbert GH, Goldberg K, Hauley R, Hashimoto M, Holmes J, Latzke B, Leroux B, Lindblad A, Richman J, Safford M, Ship J, Thompson VP, Williams OD, Yin W.
    J Dent Res; 2011 Apr; 90(4):439-44. PubMed ID: 21317246
    [Abstract] [Full Text] [Related]

  • 13. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Al Mardini M, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, St-Marie LG, Brown J, Evans AW, Rios L, Compston JE, Canadian Association of Oral and Maxillofacial Surgeons.
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE, Umland EM.
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G.
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.